At a glance
- Originator Pfizer
- Class Antineoplastics; Isoquinolines; Radiosensitisers; Small molecules
- Mechanism of Action DNA repair enzyme inhibitors; Poly(ADP-ribose) polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 19 Oct 2000 Profile reviewed but no significant changes made
- 29 Jul 1998 No-Development-Reported for Cancer in USA (Unknown route)
- 18 Jan 1996 Preclinical development for Cancer in USA (Unknown route)